Rxcurve
HCPCS J9357 · per 200 MG

Valrubicin injection

Products billed under this code include Valrubicin, Valstar.

Payment limit per 200 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9357

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Valrubicin Hikma Pharmaceuticals USA Inc. 24201-0101-04 4 $4,922.656
Valstar Endo USA, Inc. 67979-0001-01 4 $4,922.656

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1,230.664 −$16.383 200 MG Valrubicin injection v1, posted September 17, 2026
3Q26 $1,247.047 −$23.477 200 MG Valrubicin injection v1, posted September 15, 2026
2Q26 $1,270.524 −$32.818 200 MG Valrubicin injection v1, posted September 15, 2026
1Q26 $1,303.342 −$20.003 200 MG Valrubicin injection v1, posted September 15, 2026
4Q25 $1,323.345 −$53.44 200 MG Valrubicin injection v1, posted September 8, 2026
3Q25 $1,376.785 −$67.765 200 MG Valrubicin injection v1, posted March 10, 2026
2Q25 $1,444.55 +$52.032 200 MG Valrubicin injection v1, posted March 10, 2026
1Q25 $1,392.518 −$44.56 200 MG Valrubicin injection v1, posted December 19, 2025
4Q24 $1,437.078 −$16.719 200 MG Valrubicin injection v1, posted June 11, 2025
3Q24 $1,453.797 +$106.112 200 MG Valrubicin injection v1, posted June 11, 2025
2Q24 $1,347.685 −$16.163 200 MG Valrubicin injection v1, posted March 11, 2025
1Q24 $1,363.848 −$62.804 200 MG Valrubicin injection v1, posted December 19, 2024
4Q23 $1,426.652 +$34.853 200 MG Valrubicin injection v1, posted October 10, 2024
3Q23 $1,391.799 −$50.735 200 MG Valrubicin injection v1, posted June 5, 2024
2Q23 $1,442.534 +$11.149 200 MG Valrubicin injection v1, posted February 23, 2024
1Q23 $1,431.385 −$13.533 200 MG Valrubicin injection v1, posted December 6, 2023
4Q22 $1,444.918 +$7.071 200 MG Valrubicin injection v1, posted June 22, 2023
3Q22 $1,437.847 +$25.621 200 MG Valrubicin injection v1, posted June 9, 2023
2Q22 $1,412.226 −$23.432 200 MG Valrubicin injection v1, posted December 14, 2022
1Q22 $1,435.658 +$10.289 200 MG Valrubicin injection v1, posted June 8, 2022
4Q21 $1,425.369 +$42.945 200 MG Valrubicin injection v1, posted June 2, 2022
3Q21 $1,382.424 −$27.191 200 MG Valrubicin injection v1, posted June 2, 2022
2Q21 $1,409.615 −$0.791 200 MG Valrubicin injection v1, posted March 1, 2022
1Q21 $1,410.406 – 200 MG Valrubicin injection v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files